Global Inflammatory Bowel Disease Therapeutics Market Research Report 2023

Report ID: 1898434 | Published Date: Jan 2025 | No. of Page: 80 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Inflammatory Bowel Disease Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Anti-inflammatory Biologics
        1.2.3 Non-Steroidal Anti-inflammatory drugs (NSAIDs)
        1.2.4 Corticosteroids
    1.3 Market by Application
        1.3.1 Global Inflammatory Bowel Disease Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Use
        1.3.3 Home Use
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Inflammatory Bowel Disease Therapeutics Market Perspective (2017-2028)
    2.2 Inflammatory Bowel Disease Therapeutics Growth Trends by Region
        2.2.1 Inflammatory Bowel Disease Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Inflammatory Bowel Disease Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Inflammatory Bowel Disease Therapeutics Market Dynamics
        2.3.1 Inflammatory Bowel Disease Therapeutics Industry Trends
        2.3.2 Inflammatory Bowel Disease Therapeutics Market Drivers
        2.3.3 Inflammatory Bowel Disease Therapeutics Market Challenges
        2.3.4 Inflammatory Bowel Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Inflammatory Bowel Disease Therapeutics Players by Revenue
        3.1.1 Global Top Inflammatory Bowel Disease Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Inflammatory Bowel Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Inflammatory Bowel Disease Therapeutics Revenue
    3.4 Global Inflammatory Bowel Disease Therapeutics Market Concentration Ratio
        3.4.1 Global Inflammatory Bowel Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease Therapeutics Revenue in 2021
    3.5 Inflammatory Bowel Disease Therapeutics Key Players Head office and Area Served
    3.6 Key Players Inflammatory Bowel Disease Therapeutics Product Solution and Service
    3.7 Date of Enter into Inflammatory Bowel Disease Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Inflammatory Bowel Disease Therapeutics Breakdown Data by Type
    4.1 Global Inflammatory Bowel Disease Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Type (2023-2028)
5 Inflammatory Bowel Disease Therapeutics Breakdown Data by Application
    5.1 Global Inflammatory Bowel Disease Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Inflammatory Bowel Disease Therapeutics Market Size (2017-2028)
    6.2 North America Inflammatory Bowel Disease Therapeutics Market Size by Country (2017-2022)
    6.3 North America Inflammatory Bowel Disease Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Inflammatory Bowel Disease Therapeutics Market Size (2017-2028)
    7.2 Europe Inflammatory Bowel Disease Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Inflammatory Bowel Disease Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Inflammatory Bowel Disease Therapeutics Market Size (2017-2028)
    9.2 Latin America Inflammatory Bowel Disease Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Inflammatory Bowel Disease Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbvie
        11.1.1 Abbvie Company Detail
        11.1.2 Abbvie Business Overview
        11.1.3 Abbvie Inflammatory Bowel Disease Therapeutics Introduction
        11.1.4 Abbvie Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
        11.1.5 Abbvie Recent Development
    11.2 Johnson & Johnson
        11.2.1 Johnson & Johnson Company Detail
        11.2.2 Johnson & Johnson Business Overview
        11.2.3 Johnson & Johnson Inflammatory Bowel Disease Therapeutics Introduction
        11.2.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
        11.2.5 Johnson & Johnson Recent Development
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Detail
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Introduction
        11.3.4 GlaxoSmithKline Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
        11.3.5 GlaxoSmithKline Recent Development
    11.4 Merck
        11.4.1 Merck Company Detail
        11.4.2 Merck Business Overview
        11.4.3 Merck Inflammatory Bowel Disease Therapeutics Introduction
        11.4.4 Merck Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
        11.4.5 Merck Recent Development
    11.5 Novartis
        11.5.1 Novartis Company Detail
        11.5.2 Novartis Business Overview
        11.5.3 Novartis Inflammatory Bowel Disease Therapeutics Introduction
        11.5.4 Novartis Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
        11.5.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Inflammatory Bowel Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Anti-inflammatory Biologics
    Table 3. Key Players of Non-Steroidal Anti-inflammatory drugs (NSAIDs)
    Table 4. Key Players of Corticosteroids
    Table 5. Global Inflammatory Bowel Disease Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Inflammatory Bowel Disease Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Inflammatory Bowel Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Inflammatory Bowel Disease Therapeutics Market Share by Region (2017-2022)
    Table 9. Global Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Inflammatory Bowel Disease Therapeutics Market Share by Region (2023-2028)
    Table 11. Inflammatory Bowel Disease Therapeutics Market Trends
    Table 12. Inflammatory Bowel Disease Therapeutics Market Drivers
    Table 13. Inflammatory Bowel Disease Therapeutics Market Challenges
    Table 14. Inflammatory Bowel Disease Therapeutics Market Restraints
    Table 15. Global Inflammatory Bowel Disease Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Inflammatory Bowel Disease Therapeutics Market Share by Players (2017-2022)
    Table 17. Global Top Inflammatory Bowel Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease Therapeutics as of 2021)
    Table 18. Ranking of Global Top Inflammatory Bowel Disease Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Inflammatory Bowel Disease Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Inflammatory Bowel Disease Therapeutics Product Solution and Service
    Table 22. Date of Enter into Inflammatory Bowel Disease Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Inflammatory Bowel Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Type (2017-2022)
    Table 26. Global Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Type (2023-2028)
    Table 28. Global Inflammatory Bowel Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Application (2017-2022)
    Table 30. Global Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Application (2023-2028)
    Table 32. North America Inflammatory Bowel Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Inflammatory Bowel Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Inflammatory Bowel Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Inflammatory Bowel Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Inflammatory Bowel Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Inflammatory Bowel Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Abbvie Company Detail
    Table 43. Abbvie Business Overview
    Table 44. Abbvie Inflammatory Bowel Disease Therapeutics Product
    Table 45. Abbvie Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 46. Abbvie Recent Development
    Table 47. Johnson & Johnson Company Detail
    Table 48. Johnson & Johnson Business Overview
    Table 49. Johnson & Johnson Inflammatory Bowel Disease Therapeutics Product
    Table 50. Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 51. Johnson & Johnson Recent Development
    Table 52. GlaxoSmithKline Company Detail
    Table 53. GlaxoSmithKline Business Overview
    Table 54. GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Product
    Table 55. GlaxoSmithKline Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 56. GlaxoSmithKline Recent Development
    Table 57. Merck Company Detail
    Table 58. Merck Business Overview
    Table 59. Merck Inflammatory Bowel Disease Therapeutics Product
    Table 60. Merck Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 61. Merck Recent Development
    Table 62. Novartis Company Detail
    Table 63. Novartis Business Overview
    Table 64. Novartis Inflammatory Bowel Disease Therapeutics Product
    Table 65. Novartis Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 66. Novartis Recent Development
    Table 67. Research Programs/Design for This Report
    Table 68. Key Data Information from Secondary Sources
    Table 69. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Inflammatory Bowel Disease Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Anti-inflammatory Biologics Features
    Figure 3. Non-Steroidal Anti-inflammatory drugs (NSAIDs) Features
    Figure 4. Corticosteroids Features
    Figure 5. Global Inflammatory Bowel Disease Therapeutics Market Share by Application in 2021 & 2028
    Figure 6. Hospital Use Case Studies
    Figure 7. Home Use Case Studies
    Figure 8. Inflammatory Bowel Disease Therapeutics Report Years Considered
    Figure 9. Global Inflammatory Bowel Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Inflammatory Bowel Disease Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Inflammatory Bowel Disease Therapeutics Market Share by Region: 2021 VS 2028
    Figure 12. Global Inflammatory Bowel Disease Therapeutics Market Share by Players in 2021
    Figure 13. Global Top Inflammatory Bowel Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease Therapeutics as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease Therapeutics Revenue in 2021
    Figure 15. North America Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Inflammatory Bowel Disease Therapeutics Market Share by Country (2017-2028)
    Figure 17. United States Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Inflammatory Bowel Disease Therapeutics Market Share by Country (2017-2028)
    Figure 21. Germany Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Share by Region (2017-2028)
    Figure 29. China Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Inflammatory Bowel Disease Therapeutics Market Share by Country (2017-2028)
    Figure 37. Mexico Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Share by Country (2017-2028)
    Figure 41. Turkey Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Abbvie Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
    Figure 44. Johnson & Johnson Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
    Figure 45. GlaxoSmithKline Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
    Figure 46. Merck Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
    Figure 47. Novartis Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbvie
Johnson & Johnson
GlaxoSmithKline
Merck
Novartis
Frequently Asked Questions
Inflammatory Bowel Disease Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Inflammatory Bowel Disease Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Inflammatory Bowel Disease Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Instant Tea Premix

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More